OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

IGM Biosciences (NASDAQ:IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug ...

Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Melton council will investigate the feasibility of installing traffic lights at an intersection which “poses a particular ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell ...

Stocks like GTPL Hathway, Adani Total Gas, Polyplex Corporation, SRF, Equitas Small Finance Bank, Samvardhana Motherson ...